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Abstract
Calorie	restriction	(CR),	which	lengthens	lifespan	in	many	species,	is	associated	with	
moderate hyperadrenocorticism and attenuated inflammation. Given the anti‐inflam‐
matory	action	of	glucocorticoids,	we	tested	the	hypothesis	that	the	hyperadrenocor‐
ticism	 of	 CR	 contributes	 to	 its	 attenuated	 inflammatory	 response.	 We	 used	 a	
corticotropin‐releasing‐hormone	knockout	(CRHKO)	mouse,	which	is	glucocorticoid	
insufficient.	There	were	four	controls	groups:	CRHKO	mice	and	wild‐type	(WT)	lit‐
termates	fed	either	ad	libitum	(AL)	or	CR	(60%	of	AL	food	intake),	and	three	experi‐
mental	groups:	(a)	AL‐fed	CRHKO	mice	given	corticosterone	(CORT)	in	their	drinking	
water	titrated	to	match	the	integrated	24‐hr	plasma	CORT	levels	of	AL‐fed	WT	mice,	
(b)	CR‐fed	CRHKO	mice	given	CORT	to	match	the	24‐hr	CORT	levels	of	AL‐fed	WT	
mice,	and	 (c)	CR‐fed	CHRKO	mice	given	CORT	to	match	the	24‐hr	CORT	 levels	of	
CR‐fed	WT	mice.	 Inflammation	was	measured	volumetrically	as	footpad	edema	in‐
duced	 by	 carrageenan	 injection.	 As	 previously	 observed,	 CR	 attenuated	 footpad	
edema	in	WT	mice.	This	attenuation	was	significantly	blocked	in	CORT‐deficient	CR‐
fed	CRHKO	mice.	Replacement	of	CORT	in	CR‐fed	CRHKO	mice	to	the	elevated	lev‐
els	observed	in	CR‐fed	WT	mice,	but	not	to	the	levels	observed	in	AL‐fed	WT	mice,	
restored the anti‐inflammatory effect of CR. These results indicate that the hyper‐
adrenocorticism	of	CR	contributes	to	the	anti‐inflammatory	action	of	CR,	which	may	
in	turn	contribute	to	its	life‐extending	actions.
K E Y W O R D S
aging,	calorie	restriction,	corticosterone,	CRH,	inflammation,	mouse
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1  | INTRODUC TION, RESULTS,  AND 
DISCUSSION
Calorie	 restriction	 (CR)	 is	 among	 the	 most	 robust	 ways	 to	 ex‐
tend lifespan and delay age‐related diseases in mammals 
(Fontana,	Partridge,	&	Longo,	2010;	Weindruch	&	Walford,	1988).	
Considerable	 evidence	 in	 both	 invertebrates	 (Libert	 et	 al.,	 2007)	
and	mammals	 (Minor,	Chang,	&	Cabo,	2009;	Park	et	al.,	2017)	 in‐
dicates	that	cell	nonautonomous	factors,	often	driven	by	neuroen‐
docrine	 signaling,	play	an	essential	 role	 in	mediating	 the	 life‐	 and	
health‐span	 enhancing	 effects	 of	 CR.	 Less	 is	 known	 about	 the	
specific hormone targets of these neuroendocrine factors that ul‐
timately promote the health‐enhancing CR state. CR lowers plasma 
concentrations	of	numerous	anabolic	hormones,	 including	growth	
hormone	(GH),	insulin,	and	insulin‐like	growth	factor	1	(IGF1),	which	
may	be	contributors	(Masoro,	2009;	Weindruch	&	Walford,	1988).	
By	 contrast,	 glucocorticoids,	which	 play	 a	major	 role	 in	 respond‐
ing	to	stressors	(Munck,	Guyre,	&	Holbrook,	1984),	are	elevated	in	
CR	animals	(Han,	Evans,	Shu,	Lee,	&	Nelson,	2001;	Klebanov,	Diais,	
Stavinoha,	 Suh,	 &	 Nelson,	 1995;	 Sabatino,	Masoro,	McMahan,	 &	
Kuhn,	1991),	although	again	their	roles	have	not	be	delineated.
Glucocorticoids	are	anti‐inflammatory	(Munck	et	al.,	1984),	and	
attenuated	 inflammation	 is	widely	observed	 in	CR	animals	 (Frame,	
Hart,	&	Leakey,	1998;	Masoro,	2009).	We	found,	for	example,	that	
CR	mice	exhibited	 attenuated	 inflammation	when	challenged	with	
a natural polysaccharide obtained from edible seaweeds and an in‐
flammatory	agent,	carrageenan	(Klebanov	et	al.,	1995).	These	obser‐
vations have led to the hypothesis that the hyperadrenocorticism 
of CR contributes to the attenuation of inflammation in CR animals 
(Klebanov	et	al.,	1995;	Leakey	et	al.,	1994).
Here,	we	 tested	 this	 hypothesis	 directly	 using	 a	 corticotropin‐
releasing	hormone	knockout	 (CRHKO)	mouse,	which	 is	glucocorti‐
coid	deficient	(Muglia,	Jacobson,	Dikkes,	&	Majzoub,	1995)	and	has	
increased	 inflammation	 following	 allergen	 exposure	 (Silverman	 et	
al.,	2004).	We	first	established	that	the	anti‐inflammatory	response	
to	CR	was	inhibited	in	these	CORT‐deficient	mice.	We	then	tested	
whether the hyperadrenocorticism of CR was required to rescue the 
anti‐inflammatory status associated with CR or whether the eu‐ad‐
renocortical	state	of	AL	mice	was	sufficient.	This	was	accomplished	
by	titrating	CORT	in	the	drinking	water	of	CHRKO	mice	to	match	the	
integrated	24‐hr	plasma	CORT	levels	of	AL‐fed	and	CR‐fed	WT	mice,	
respectively	(Supporting	Information	Figure	S1).
As	previously	reported	(Han	et	al.,	2001;	Klebanov	et	al.,	1995;	
Sabatino	et	al.,	1991),	CR	markedly	elevated	plasma	CORT	 in	WT	
mice	 (Figure	 1a,c).	 CORT	 levels	 integrated	 over	 the	 entire	 day	
were	 over	 twofold	 higher	 in	 CR	WT	 than	AL	WT	mice	 (p	<	0.05,	
Figure	1c).	In	AL	WT	mice,	CORT	levels	peaked	during	the	dark	phase	
(Figure	1a).	By	contrast,	CORT	levels	in	CR	WT	mice	peaked	during	
the	light	period	and	fell	rapidly	after	feeding	(Figure	1a).	Consistent	
with	previous	studies	 (Muglia	et	al.,	1995),	CORT	 levels	of	AL‐fed	
CRHKO	mice	were	markedly	 reduced	 (Figure	1a,c).	Moreover,	CR	
failed	to	increase	CORT	levels	in	CRHKO	mice	(Figure	1a,c).	These	
results	indicate	that	elevation	of	CORT	by	CR	requires	CRH.
Figure	1b	shows	the	plasma	CORT	profiles	of	CRHKO	mice	given	
CORT	in	the	drinking	water	to	mimic	CORT	levels	in	WT	AL	and	CR	
mice	(7	and	55	μg/ml	of	CORT,	respectively).	Integrated	24‐hr	levels	
of	CORT	in	both	AL	and	CR	CRHKO	mice	replaced	with	7	μg/ml of 
CORT were similar and markedly increased above vehicle‐treated 
CRHKO	 mice—approaching,	 albeit	 less	 than,	 levels	 of	 their	 WT	
counterparts	(Figure	1c).	Although	this	replacement	regimen	yielded	
a	circadian	fluctuation	of	CORT	levels	 in	CR‐fed	CRHKO	mice,	the	
pattern	was	shifted	 from	the	diurnal	elevation	 in	CR‐fed	WT	mice	
to a sharp circadian peak tightly coupled to the time of feeding of 
the	restricted	food	allotment	(cf:	Figure	1a,b).	CR‐fed	CRHKO	mice	
given 55 μg/ml of CORT had a markedly greater postfeeding spike in 
plasma	CORT,	and	the	 integrated	24‐hr	 levels	were	comparable	to	
F I G U R E  1   Circadian profile of plasma 
CORT	over	the	24‐hr	period	in	WT	and	
CRHKO	mice	fed	AL	or	CR.	(a)	The	profile	
from	WT	and	CRHKO	mice	fed	AL	or	CR.	
(b)	CRHKO	mice	replaced	with	CORT	in	
their	drinking	water	(at	7	or	55	µg/ml)	to	
achieve	WT	AL	or	CR	levels,	respectively.	
(c) Represents these data calculated 
as integrated areas under the 24‐hr 
curves.	Data	are	expressed	as	mean	±	SE; 
bars with different alphabetical letters 
are statistically different (p < 0.05 by 
Duncan's a posterior test). Data were 
analyzed	by	two‐way	ANOVA
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those	of	CR	WT	mice.	In	summary,	CORT‐replaced	CRHKO	mice	had	
24‐hr integrated levels of CORT that were comparable to those of 
AL‐fed	and	CR‐fed	WT	mice,	although	the	circadian	patterns	differed	
from	those	of	WT	mice.
Using	these	groups,	we	tested	the	hypothesis	 that	 the	CR‐me‐
diated elevation of CORT plays a role in anti‐inflammatory action 
of	CR,	as	measured	by	footpad	edema	induced	by	injection	of	car‐
rageenan.	 Figure	 2a	 shows	 the	 time	 course	 of	 footpad	 edema	 in	
the	control	groups	(i.e.,	AL‐	and	CR‐fed	WT	and	CRHKO	mice),	and	
Figure	 2b	 shows	 the	 results	 in	 the	 experimental	 groups	 namely,	
CRHKO	AL	 and	CR‐fed	mice	 in	which	CORT	 levels	were	 restored	
to	levels	observed	in	WT	mice.	In	WT	AL	mice,	the	edematous	re‐
sponse following carrageenan injection had three phases: first 
increasing	to	a	peak	at	72	hr	post	injection	of	carrageenan,	then	de‐
creasing	steadily	thereafter	until	120	hr,	when	it	plateaued	at	an	el‐
evated	level	until	measurement	ceased.	We	analyzed	the	edematous	
responses	in	each	of	these	phases	(increasing,	decreasing,	plateau)	
as	the	integrated	areas	under	the	time‐course	curves,	because	the	
responses	of	 the	experimental	groups	did	not	always	vary	propor‐
tionately across the three phases.
The time course of the edematous response to carrageenan 
during	 the	 increasing	 phase	 is	 shown	 in	 Figure	 2a,b	 and	 the	 inte‐
grated	areas	under	the	time‐course	curve	in	Figure	2c.	During	this	
phase,	CR	reduced	edema	by	60%	(p	<	0.05)	in	WT	mice,	consistent	
with	our	earlier	study	in	WT	BALB/c	mice	(Klebanov	et	al.,	1995).	By	
contrast,	in	CRHKO	mice,	CR	only	reduced	edema	by	30%	(p < 0.05). 
Edema	in	CR‐fed	CRHKO	mice	was	more	than	twice	that	of	CR	WT	
mice (p	<	0.05).	In	addition,	the	edema	in	AL‐fed	CRHKO	mice	during	
this	phase	was	20%	greater	than	that	of	AL‐fed	WT	mice	(p < 0.05). 
CORT	 replacement	 in	 drinking	 water	 in	 CRHKO	mice	 at	 7	μg/ml,	
which	approached	levels	observed	in	AL‐fed	WT	mice,	rescued	the	
edema	response	under	AL	feeding	but	not	under	CR.	Only	CORT	re‐
placement at 55 μg/ml,	which	matched	the	levels	observed	in	CR‐fed	
WT	mice,	rescued	the	inflammatory	suppression	observed	in	AL‐fed	
WT	mice.
The time course of the edematous response to carrageenan 
during	 the	decreasing	phase	 is	 shown	 in	Figure	2a,b	 and	 the	 in‐
tegrated	areas	under	 the	time‐course	curve	 in	Figure	2d.	During	
this	 phase,	 edema	 continued	 to	 be	 reduced	 by	 CR	 in	WT	 mice	
(p	<	0.05)	but	was	not	reduced	by	CR	in	CRHKO	mice.	In	contrast	
to	the	increasing	phase,	CRH	deficiency	had	no	effect	on	edema	
in	AL‐fed	mice.	CORT	replacement	in	CRHKO	mice	had	similar	ef‐
fects in the decreasing response phase to those observed during 
the	 increasing	 phase.	Only	 replacement	 of	 CORT	 to	CR‐fed	WT	
levels	reduced	edema	in	CR‐fed	CRHKO	mice	to	that	observed	in	
CR‐fed	WT	mice.
The time course of the edematous response to carra‐
geenan	 during	 the	 plateau	 phase	 is	 shown	 in	 Figure	 2a,b	 and	
F I G U R E  2  Time	course	of	the	inflammatory	response	to	an	intraplantar	injection	of	carrageenan.	(a)	The	responses	from	AL	and	CR	
WT	and	CHRKO	mice.	(b)	AL	and	CR	CHRKO	mice	replaced	with	CORT	to	achieve	WT	AL	(7	µg/ml)	and	CR	(55	µg/ml)	plasma	CORT	
levels.	Edema	was	expressed	as	%	difference	from	baseline	from	the	increase	in	paw	volume	(ml)	after	carrageenan	injection	relative	to	
the preinjection value for each animal (n	=	10–12	except	for	CR	CRHKO	n	=	6).	The	response	(a	and	b)	was	subdivided	into	three	phases	
delineating	the	(c)	increase,	(d)	decrease,	and	(e)	plateau	phases	of	the	inflammatory	response	in	WT	AL	mice.	The	dark	bars	represent	
WT	and	CRHKO	AL	and	CR	mice.	The	light	bars	represent	CRHKO	mice	CORT	replaced	at	7	and	55	µg/ml	to	mimic	CORT	levels	in	WT	AL	
and	CR	mice,	respectively.	Data	are	expressed	as	mean	±	SE; bars with different alphabetical letters are statistically different (p < 0.05 by 
Duncan's	a	posterior	test).	Data	were	analyzed	by	two‐way	ANOVA
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the	 integrated	areas	under	 the	 time‐course	 curve	 in	Figure	2e.	
During	 this	 phase,	CR	did	 not	 suppress	 edema	 in	WT	mice.	By	
contrast,	CR	exacerbated	edema	 in	CRHKO	mice	 (p	<	0.05),	 in‐
creasing	 it	by	40%	relative	to	both	AL‐fed	CRHKO	mice	as	well	
as	both	AL‐	and	CR‐fed	WT	controls.	In	contrast	to	the	other	two	
phases	of	edema,	CORT	replacement	in	CR‐fed	CRHKO	mice	to	
AL	WT	 levels	 (7	μg/ml)	 was	 sufficient	 to	 suppress	 edema,	 and	
CORT	 replacement	 to	CR‐fed	WT	 levels	 (55	μg/ml) had no fur‐
ther effect.
It should be noted that the 24‐hr patterns of plasma CORT in 
the	 CRHKO	mice	with	 CORT	 replacement	 in	 their	 drinking	water	
(Figure	1b)	differed	 strikingly	 from	 the	profile	of	CORT	 in	WT	CR	
mice	 (Figure	 1a)	 both	 in	 the	magnitude	 of	 the	 circadian	 variation	
and the timing of the peak. These differences may reflect an in‐
tense period of drinking associated with the rapid consumption of 
the	 restricted	 allotment	 of	 food	 given	 the	 CR	mice,	 compared	 to	
the	more	evenly	distributed	food	and	water	 intake	of	AL‐fed	mice.	
Nevertheless,	at	least	for	the	specific	outcome	of	this	study,	the	role	
of elevated CORT in the suppression of the edematous response 
to carrageenan appears to mainly result from the 24‐hr integrated 
levels of plasma CORT independent of the timing or magnitude of 
circadian variation.
The major finding of this study was that the hyperadrenocortical 
state associated with CR is required for the attenuation by CR of 
footpad edema in response to carrageenan administration in mice. 
This is the first direct evidence linking elevated glucocorticoids to 
the	 reduced	 inflammatory	 tone	 associated	with	CR,	 a	well‐known	
characteristic	of	CR	that	is	a	plausible	contributor	to	the	life‐extend‐
ing effects of CR.
Paradoxically,	 hyperadrenocorticism	 is	well	 known	 to	 be	 det‐
rimental	 to	 health	 and	 lifespan.	 In	 humans,	 chronically	 elevated	
glucocorticoids	are	associated	with	insulin	resistance	(Anagnostis,	
Athyros,	Tziomalos,	Karagiannis,	&	Mikhailidis,	2009)	and	are	 the	
cause	of	Cushing's	syndrome,	a	life‐threatening	disorder	of	gluco‐
corticoid	overproduction	(Raff	&	Findling,	2003).	Chronic	elevation	
of	CORT	levels	increases	the	risk	of	hypertension,	hyperkalemia,	di‐
abetes,	atherosclerosis,	osteoporosis,	glaucoma,	and	impairment	of	
the	immune	and	reproductive	systems	(McEwen	&	Sapolsky,	1995).	
Elevation	 of	 CORT	 damages	 hippocampal	 cells	 in	 rats	 (Sapolsky,	
Krey,	 &	McEwen,	 1985),	 which	 in	 turn	 is	 associated	with	 neuro‐
degeneration	and	cognitive	 impairment	 in	rodents	 (Patel	&	Finch,	
2002).	However,	 all	 evidence	 for	 deleterious	 effects	 of	 hyperad‐
renocorticism occurs under conditions of ad libitum food intake. 
There is no evidence that the hyperadrenocorticism associated 
with CR is deleterious. The results of this study suggest that it may 
be	 beneficial—to	 the	 extent	 that	 resilience	 against	 inflammatory	
stressors is advantageous for the organism. These results not only 
suggest glucocorticoids are necessary for the anti‐inflammatory 
actions	of	CR	in	mice	(Chung,	Kim,	Kim,	Choi,	&	Yu,	2002;	Klebanov	
et	al.,	1995)	but	also	buttress	previous	 results	 that	hyperadreno‐
corticism of CR may be involved in the retardation of aging by CR 
(Klebanov	et	al.,	1995;	Leakey	et	al.,	1994;	Masoro,	2009;	Sabatino	
et	al.,	1991).
2  | MATERIAL S AND METHODS
2.1 | Animal husbandry
We	used	CRHKO	mice	and	WT	littermate	controls	to	probe	the	role	
of	 hyperadrenocorticism	 in	 CR.	 CRHKO	mice	 lack	 normal	 circa‐
dian variations in plasma adrenocorticotropic hormone and CORT 
(Muglia	et	al.,	1995).	Animals	used	in	this	study	were	backcrossed	
with	C57BL/6J	(B6)	mice	to	generate	a	genetically	defined	strain.	
However,	by	the	sixth	backcross	to	B6,	the	null	allele	homozygote	
(i.e.,	 CRHKO)	was	 found	 to	 be	 lethal	 in	 the	B6	 background.	We	
discovered that this lethality could be overcome by crossing mice 
carrying	the	null	CRH	allele	with	DBA/2J	(D2)	animals	and	breed‐
ing	the	resultant	B6/D2	F1	progeny	heterozygous	for	the	CRH	null	
allele.	 This	 strategy	 produced	 viable	 B6/D2	 F2 CRHKO	 and	WT	
mice	 that	approached	the	expected	Mendelian	 inheritance	ratio.	
We	used	 this	breeding	strategy	with	CRH	null	mice	backcrossed	
into	B6	to	the	10th	generation.	The	mice	for	this	study	were	bred	
and	maintained	 in	 the	 Aging	 Animal	 Core	 of	 The	Nathan	 Shock	
Center	 and	were	 born	within	 a	 3‐month	 period.	 At	 4	months	 of	
age,	the	animals	were	assigned	to	treatment	groups.	All	mice	were	
fed	 a	 commercial	 chow	 (Teklad	Diet	 LM485:	Madison	WI)	 ad	 li‐
bitum	 (AL)	 or	 calorie	 restricted	 (fed	 once	 a	 day	 at	 15:00	hr).	 CR	
was	 introduced	 incrementally;	 mice	 were	 restricted	 80%	 of	 AL	
the	first	week	and	60%	subsequently.	AL	food	consumption	was	
determined by measuring the amount of chow removed from the 
cage hopper and then subtracting the spillage (chow found on the 
cage	 floor).	 Animals	 were	 housed	 four	 per	 cage	 in	 a	 room	with	
controlled	temperature	(72°F)	and	fixed	light	cycle	(lights	on	from	
06:00	to	18:00	hr).	All	animals	had	free	access	to	water,	or	water	
plus	 CORT	 replacement	 at	 7	μg/ml or 55 μg/ml (CORT was pur‐
chased	from	Steraloids	Inc.	Newport	R.I).	All	procedures	followed	
the	guidelines	approved	by	the	Institutional	Animal	Care	and	Use	
Committee	 at	 the	University	 of	 Texas	Health	 Science	 Center	 at	
San	Antonio	and	South	Texas	Veterans	Health	Care	System,	Audie	
L.	 Murphy	 Division,	 and	 are	 consistent	 with	 the	 NIH	 Principles	
for	the	Utilization	and	Care	of	Vertebrate	Animal	Used	in	Testing,	
Research	 and	 Education,	 the	 Guide	 for	 the	 Care	 and	 Use	 of	
Laboratory	 Animals	 and	 Animal	Welfare	 Act	 (National	 Academy	
Press,	Washington,	DC).
2.2 | Experimental design
To	demonstrate	the	efficacy	of	CORT	replacement	in	GRH	KO	mice,	
the	 experimental	 design	 and	 expected	 results	 are	 illustrated	 in	
Supporting	Information	Figure	S1.	This	study	had	seven	treatment	
groups,	illustrated	in	Supporting	Information	Figure	S1.	There	were	
four	controls	groups,	WT	and	CRHKO	littermates	fed	either	AL	or	
CR.	Two	of	CRHKO	groups,	one	fed	AL	and	one	CR,	were	included	
to	determine	the	effect	of	CRH	and	CORT	deficiency	on	the	inflam‐
matory	response	to	CR.	There	were	three	experimental	groups	using	
CRHKO	mice.	Among	 these	 three	groups,	one	 fed	AL	and	one	CR	
were	 CORT‐replaced	 at	 7	μg/ml drinking water to determine the 
effect	 of	 replacing	 CORT	 to	 WT	 AL	 levels	 on	 the	 inflammatory	
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response.	The	third	group	was	a	CRHKO	CR	group	that	was	CORT‐
replaced at 55 μg/ml to determine the effect of CORT replacement 
to	WT	CR	level	on	the	inflammatory	response.
These replacement dosages were determined from preliminary 
titration	 studies	of	CORT	 in	 the	drinking	water.	All	 animals	began	
CORT	replacement	at	the	commencement	of	CR.	Group	sample	size	
was	 between	 10	 and	 12	with	 the	 exception	 of	 the	 non‐CORT‐re‐
placed	CRHKO	CR	group	 (n	=	6).	This	smaller	 sample	size	was	due	
to	deaths	that	were	unique	to	this	group.	All	mice	were	subjected	to	
these feeding and CORT replacement conditions for 5 months be‐
fore tested for inflammatory responsiveness.
2.3 | Plasma collection and CORT measurements
A	plasma	CORT	profile	was	obtained	for	each	group	using	additional	
mice.	Blood	collected	by	tail	bleeding	at	08:00,	14:00,	16:00,	18:00,	
20:00,	and	22:00	hr	 (each	animal	was	bled	at	each	 time	point).	To	
minimize	 the	 effect	 of	 handling	 stress	 on	 CORT	 levels,	 bleedings	
were performed at least 3 days apart and were completed within 
2 min of initial disturbance of the animal. Only one animal from 
each cage was removed for measurement at any time. Individual 
animals	were	 restrained	 exposing	 the	 tail	where	 a	 10mm	cut	was	
made	 lengthwise	 and	 blood	was	 drawn	 into	 a	 75‐mm	heparinized	
capillary tube. Plasma was immediately prepared by centrifugation 
and	stored	at	−80°C.	CORT	was	measured	using	a	125I corticoster‐
one	 radioimmunoassay	kit	 (ICN	Pharmaceuticals,	 Inc.	Costa	Mesa,	
CA).	 The	 standard	 curves	were	 linear	 (r2 > 0.99) within a range of 
25–1,000	ng/ml.
2.4 | Chemicals
One	 day	 prior	 to	 the	 experiment,	 a	 2%	 solution	 of	 Type	 IV	
Carrageenan	 (Sigma‐Aldrich)	 was	 prepared	 in	 0.9%	 sterile	 saline	
allowing	the	compound	to	hydrate	and	solubilize.	The	mixture	was	
vortexed	and	inverted	in	a	1.7‐ml	micro‐tube	and	allowed	to	stand	
overnight	at	4°C.	The	morning	of	the	experiment,	the	solution	was	
vigorously	mixed	and	pulse	 spun	before	 loading	 into	a	0.5‐ml	LO‐
DOSE	insulin	syringe	with	a	fixed	29G	(0.33	×	13	mm)	needle.
2.5 | Edema induction and measurement
Footpad	edema	was	measured	using	a	plethysmometer	(Model	7140	
Ugo	Basile,	 Italy).	Edema	was	measured	by	 immersing	the	 footpad	
into	the	chamber	fluid	exactly	to	the	carpel	joint.	The	plethysmome‐
ter was calibrated before each series of measurements. The morning 
of	the	experiment,	 individual	animals	were	weighed	and	a	baseline	
foot measurement was recorded. The animals were restrained by 
rolling	the	upper‐half	of	the	body	in	cloth	leaving	the	hind	legs	ex‐
posed where the left paw was injected with 20 μl of carrageenan. 
The footpad was approached from the toes and injected deeply into 
the	plantar	muscle	bundle	to	avoid	leakage.	All	injections	were	com‐
pleted	between	07:30	and	08:00	hr.	The	animals	were	then	returned	
to	their	cages	until	measurements	at	2,	4,	8,	12,	24,	48,	72,	96,	120,	
144,	and	168	hr.	The	injected	animals	remained	in	the	animal	colony	
under	routine	conditions.	All	the	feeding	regimens	and	CORT	sup‐
plementation	continued	to	occur	during	the	168	hr	of	inflammation	
testing.	Edema	data	are	expressed	as	percent	increase	relative	to	the	
baseline	measurement	of	the	footpad.	Each	recorded	measurement	
was the average of at least three dips. This study involved a large 
number	of	mice.	Therefore,	the	data	are	the	cumulative	result	of	five	
sequential cohorts using two mice from each of the seven treatment 
groups.
2.6 | Statistical analysis
Statistical analysis for differences among the groups was assessed 
by	ANOVA	using	Statistical	Package	for	Social	Sciences	(SPSS® Inc.,	
Chicago,	IL)	with	Duncan	as	a	post	hoc	test.	Results	are	expressed	as	
means	±	SE,	and	p values equal to or less than 0.05 were considered 
to be significantly different.
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